Enrollment:
| | | | | | | | | | |
Eligibility Screen
|
X
| | | | | | | | | |
Informed consent
|
X
| | | | | | | | | |
Socio-demographic questions
|
X
| | | | | | | | | |
Assessments:
|
X
| | | |
X
| | | | | |
HFIASa, Food frequency questionnaire
|
X
| | | |
X
| | | | | |
Clinic visit for intervention and control food supply
|
X
|
X
|
X
|
X
|
X
| | | | | |
Adherence/educational messages
|
X
|
X
|
X
|
X
|
X
| | | | | |
Surveillance of clinical events
|
X
|
X
|
X
|
X
|
X
| | | | | |
Maternal anthropometric measurements
|
X
|
X
|
X
|
X
|
X
| | | | | |
Infant anthropometric measurements
| | | | | | |
X
|
X
|
X
|
X
|
Interventions:
| | | | | | | | | | |
Food distribution
|
X
|
X
|
X
|
X
|
X
|
X
| | | | |
Bed net distribution
|
X
| | | | | | | | | |
Testing and treatment of bacterial vaginosis
|
X
| | | | |
X
| | | | |
Albendazole (400 mg)
|
X
| | | | | | | | | |
Azithromycin (1 g)
|
X
| | | | |
X
| | | | |
Sulfadoxine/ pyrimethamine (1500 mg/75 mg)
|
X
| |
X
| |
X
|
X
| | | | |